Nadia Ucciferri

Nadia Ucciferri is an accomplished professional with extensive experience in analytical development and quality control within the pharmaceutical industry. At Thermo Fisher Scientific, from June 2020 to November 2023, Nadia led a team responsible for managing clinical and commercial drug projects, emphasizing the development and validation of analytical methods. Prior roles included contributions to biomolecule drug development and stability studies at Thermo Fisher Scientific and Kedrion Biopharma, where analytical methods were developed in a GMP-like environment. Earlier experience at IFC-CNR involved managing a Proteomics Lab focused on mass spectrometry, alongside research in nanosensors and tissue engineering. Nadia's academic foundation includes a PhD in Nanotoxicology and microfluidics from Università di Pisa, complemented by an Executive Master's degree in Project Management.